Prime Medicine has entered a research partnership with Cimeio Therapeutics to develop prime edited shielded-cell and immunotherapy pairs for genetic diseases by combining their technologies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,